Investor profile
aMoon Fund has backed 10 European tech companies across 12 funding rounds between 2017 and 2024, joining rounds totalling €298M. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Also recorded as: aMoon
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Sophia Genetics | Switzerland | 1 | €94M |
| DayTwo | Israel | 2 | €58M |
| Theranica | Israel | 1 | €31M |
| MiNA Therapeutics | UK | 1 | €25M |
| Medial Earlysign | Israel |
| 1 |
| €25M |
| Zebra Medical Vision | Israel | 1 | €24M |
| Lyfegen | Switzerland | 2 | €13M |
| igentify | Israel | 1 | €9.6M |
| Ibex Medical Analytics | Israel | 1 | €9.6M |
| vocalis health | Israel | 1 | €8.3M |
| €28M |
| 2019-04 |
| MiNA Therapeutics | Series A | €25M | 2020-09 |
| Medial Earlysign | Other | €25M | 2018-01 |
| Zebra Medical Vision | Other | €24M | 2018-02 |
| igentify | Other | €9.6M | 2019-10 |
| Ibex Medical Analytics | Series A | €9.6M | 2019-01 |
| vocalis health | Other | €8.3M | 2019-10 |
